Log in

New Hampshire Alcohol & Drug Abuse Counselors Association

Dedicated to Advancing Addiction Professionals in New Hampshire


For NH job postings please complete the NHADACA Job Posting Request Form to advertise a vacant job opportunity for others to see. Once we receive the completed form, we will post it to our website within 10 business days. We will display your substance use related job post for 30 days. If you have any questions, please contact us by emailing

  • September 17, 2020 12:44 PM | Anonymous

    Alert to Billing Administrators and those responsible for submitting Medicare and Medicaid claims.

    ​Webinar on the 2021 updates for the ICD-10

    1pm EST September 22 

    This webinar will help you stay up to date and avoid delays and denials of claims!  

    The Center for Medicare and Medicaid Services annually updates the ICD diagnosis code manual on October 1st. There are 490 new codes, including those related to COVID-19 plus additional revisions and deleted codes. Not implementing these code changes in your office may cause delays or denial of professional medical claims.


    2021 Update for ICD-10-CM

    Sept 22 ,2020 | 1:00 PM ET | 12:00 PM CT | 10:00 AM PT |
    Presented By: Lynn Anderanin
    AAPC Credit : 1.0
    The Center for Medicare and Medicaid Services(CMS) annually updates the ICD-10-CM diagnoses code manual on October 1st. This year is no different. For 2021 there are 490 new codes, including those related to COVID-19, as well as 47 revised and 58 deleted codes. Not implementing these code changes in your office on October 1st may cause denial of claims and delay in reimbursement for professional medical claims.

    Join this webinar by renowned speaker Lynn Anderanin, where she will discuss all the updates in detail.

    Session highlights:

    • Changes to the Official ICD-10-CM Guidelines for 2021
    • New codes for sickle cell conditions
    • ICD-10-CM codes changes are effective on October 1, 2020
    • Codes added for vaping related disorders
    • The latest changes for COVID-19
    • Pathological fracture code expansion
    • Rheumatoid arthritis diagnoses changes
       Register Here   
    At the Q&A session following the live event,ask a question and get a direct response from Lynn.
  • September 17, 2020 12:42 PM | Anonymous

    Virtual Care: Wave Of The Future, or Momentary Ripple?

    Qualifacts and the National Council for Behavioral Health recently polled more than 1,000 behavioral health providers to see how they are faring during the COVID-19 pandemic. Read this article to learn about how our colleagues across the U.S. are handling a remote workforce, how operations and revenues are being affected, and what technology solutions are being put into place.

      Download Now

  • September 17, 2020 12:40 PM | Anonymous

    Mayo Clinic's Well-Being Index has joined the National Action Collaborative on Clinician Well-Being by becoming a Network Organization.

    Check out their recent video update on how healthcare centers are bolstering staff well-being initiatives during the pandemic

    Check out this week's video update to learn more about:

    • How medical centers are supporting clinician mental health through the COVID-19 pandemic
    • CommonSpirit Health CMO slated to speak at the Champions of Wellness Virtual Summit 2020
    • The latest findings on resident & fellow well-being 
  • September 03, 2020 3:40 PM | Anonymous
    The NBCC Minority Fellowship Program Is Now Accepting Applications for the 2021 Academic Year!
    Are you or someone you know working towards a Master's degree in the addiction field & committed to working with underserved populations?

    The National Board of Certified Counselors (NBCC) Foundation and NAADAC, the Association for Addiction Professionals, are pleased to announce the 2021 application period for the National Board for Certified Counselors Minority Fellowship Program for Addictions Counselors (NBCC MFP-AC) is now open! 

    This program is made possible by a grant awarded to the NBCC Foundation in collaboration with NAADAC by the Substance Abuse and Mental Health Services Administration (SAMHSA). The program will administer up to 40 Master’s degree-level counseling fellowships of $15,000 for addictions counseling students, plus the travel expenses to participate in other program-related trainings.

    Application deadline: December 15, 2020  


    What Fellows Receive:

    • Tuition stipends of up to $15,000;
    • Complimentary registration and travel expenses to attend the NAADAC 2021 Annual Conference in Seattle, WA;
    • Complimentary registration and travel expenses to attend the NBCC Foundation’s Bridging the Gap Symposium in 2021 and in 2022;
    • One-year complimentary NAADAC membership, which grants access to free NAADAC webinars & discounted CE-earning opportunities, reduced rates for student malpractice & liability insurance, the NAADAC Career Center, and discounted NAADAC publications;
    • Training, professional development opportunities, and mentoring from professionals in the field;
    • The opportunity to help reduce health disparities and improve healthcare outcomes of minority & LGBT populations and transition age youth (ages 16-25); and
    • The prestige of being a part of the SAMHSA-funded Minority Fellowship Program!

    Are You Eligible?

    Visit the NAADAC website to see the eligibility requirements for the NBCC MFP-AC.
  • August 14, 2020 3:17 PM | Anonymous

    The New England PTTC is pleased to announce that a limited number of scholarships are available for New England prevention professionals from each state in the region to attend New England PTTC Advanced Prevention Track courses at the 2020 Virtual New England School of Best Practices, scheduled for August 24-28, 2020. Awards will be made on a first come, first served basis to eligible New England prevention professionals.

    • Schedule for the Best Practices Conference: Schedule 2020 Virtual Best Practices
    • Schedule for the Advanced Prevention track, specifically: available on the website a the above link.

    Please share the following link to your New England prevention professionals who might benefit from participating in this advanced training opportunity:

    Please don’t hesitate to reach out to me with any questions you may have.

    Thank you,


    Erin Burnett
    Training & Outreach Coordinator | New England Prevention Technology Transfer Center | Join the New England PTTC Mailing List: Subscribe Now

    Administered by:
    AdCare Educational Institute of Maine, Inc.
    Ballard Center | 6 E. Chestnut Street, Suite 101 | Augusta, ME 04330
    Phone: 207-626-3615 | Fax: 207-621-2550

    Explore our new website at

    Attachments area
  • August 11, 2020 1:05 PM | Anonymous

    Scholarships Available for the NAADAC 2020 Annual Conference: Learn, Connect, Succeed

    NAADAC is excited to bring you the opportunity to attend its virtual 2020 Annual Conference: Learn, Connect, Succeed, on a full scholarship!

    Thanks to the generous support of the NAADAC Education and Research Foundation, NAADAC is able to provide a limited number of conference scholarships so that YOU can attend #NAADAC2020 this year and gain access to three days of virtual education, training, networking, and capacity-building with thought leaders in the addiction profession!

    Scholarships only cover the registration for the three-day NAADAC 2020 Annual Conference from September 24-26, 2020.

    To apply for a conference scholarship, please submit an application by August 23, 2020. Scholarship awardees will be notified by August 27, 2020. For those who do not receive scholarships this year, the early bird registration rate is available until August 31, 2020.


    Please visit NAADAC's webpage or contact NAADAC Director of Communications Kristin Hamilton, JD, at

  • July 21, 2020 9:31 AM | Anonymous

    Emerging Threat Bulletin from Gulf Coast HIDTA


    July 2020

    Background:  Isotonitazene, also known as “Iso” or “Toni,” is being increasingly identified in overdose deaths throughout the United States.  This synthetic opioid was first identified in August 2019 and has been most prominent in Midwestern states.  The drug is a type of benzimidazole that is structurally similar to etonitazene, a potent internationally controlled opioid.  Isotonitazene reportedly has a greater potency than heroin and morphine, and it is similar in strength to fentanyl.  Isotonitazene has been encountered mostly in powder (brown, yellow, or white) tablet, and liquid forms as well as nasal spray to a lesser degree.  Isotonitazene has also been found concealed as counterfeit Dilaudid (hydromorphone) tablets circulating in the US.  On June 18, 2020, The Acting Administrator of the DEA issued a notice of intent to publish a temporary order to schedule isotonitazene in schedule I of the Controlled Substance Act, which are drugs that are illegal and have no medical uses.  The drug is also not approved for medical use by the FDA.

    Source: China has been identified as a main source country for isotonitazene. The restrictions placed by the US on Chinese fentanyl analogues have opened the market to the shipping of isotonitazene.  The drug has been shipped from China to European and US markets with many orders originating from Darkweb vendors.  Currently, the supply of isotonitazene from China may be limited by reduced production and speed of international shipping due to the COVID-19 pandemic.  Isotonitazene can be purchased in bulk at a low cost from China.  Bulk quantities of the drug are often mixed with other drugs to reduce costs.  Isotonitazene has been most frequently identified with flualprazolam, fentanyl, heroin, and cocaine

    Overdoses:  In November 2019, there were 40 to 50 isotonitazene-related deaths per month in the United States compared to about six per month from June 2019 to August 2019 according to forensic toxicology results reported by the Naval Criminal Investigative Service Multiple Threat Alert Center. Due to the shortcomings of preliminary testing, isotonitazene has not been widely identified in laboratories throughout the US.  While formal epidemiological studies on isotonitazine use have yet to be performed, self-reported experiences on user websites suggest that dosage regimens for the drug can differ between and within individuals depending on tolerance of the user, other drugs being concurrently used, desired effects, purity and composition of the substance, and dosage consumed.  Consumers may be at a higher risk of acute poisoning as isotonitazene is often concealed in counterfeit pharmaceuticals as seen in Figure 1.  Similar to other opioids, health risks associated with isotonitazene are often respiratory depression, which in overdose could lead to apnea, respiratory arrest, and death.  Additionally, the risk of an overdose from isotonitazine is increased due to the high potency of this drug often requiring several doses of Naloxone to reverse its effects.

    Figure 1: Isotonitazene concealed in counterfeit pharmaceutical drugs often have an “M” on one side and the number “8” on the other side – making them almost identical to an 8 mg Dilaudid tablet.  Source: International Narcotics Control Board, Global Rapid Interdiction of Dangerous Substances

    Law Enforcement Encounters:   As of March 5, 2020, there have been 8 NFLIS submissions of isotonitazene in the US. However, law enforcement within the Gulf Coast HIDTA AOR have not yet encountered this drug.

    Public Health Encounters:   While isotonitazene is on the NMS Labs Toxicology radar, 5 postmortem isotonitazene cases have been identified in the Gulf Coast HIDTA jurisdiction by NPS Discovery/CFSRE & NMS Labs as of April 2020.   This information is being released to raise awareness of the unpredictability and danger of this drug. This bulletin was produced by the Gulf Coast High Intensity Drug Trafficking Area.

    Questions or comments may be directed to Strategic Programs Coordinator Sabrina Perez at (571) 362-4851 or Feedback can be provided here:   Sources: Chicago HIDTA DEA, National Forensic Laboratory Information System (NFLIS) European Monitoring Centre for Drugs and Drug Addiction International Narcotics Control Board, Global Rapid Interdiction of Dangerous Substances Journal of Analytical Toxicology Krotulski, Alex J, Donna M Papsun, Sherri L Kacinko, and Barry K Logan. “Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework.” Journal of Analytical Toxicology, 2020. Naval Criminal Investigative Service, Multiple Threat Alert Center, Threat Division U.S. Department of Homeland Security, U.S. Customs and Border Protection 1 Specified data for Shelby County, TN, Escambia County, FL, and Santa Rosa County, FL was not available. 

  • July 14, 2020 12:28 PM | Anonymous

    New Hampshire Medicaid Program


    Provider Relief Fund: Medicaid & CHIP Provider Distribution  
    On June 9, 2020, the U.S. Department of Health and Human Services (HHS) announced the distribution of approximately $15 billion from the Provider Relief Fund to eligible providers that participate in state Medicaid programs and Children’s Health Insurance Program (CHIP) and have not received a payment from the Provider Relief Fund General Distribution.
    The payment to each provider will be approximately 2 percent of reported gross revenue from patient care; the final amount each provider receives will be determined after the data is submitted.
    Funds will be distributed to eligible providers who apply through the Provider Relief Fund portal. The portal will be open until July 20, 2020. All eligible Medicaid/CHIP providers are encouraged to apply.
    How to Apply For Funding:

    1. Visit and choose “For Providers.”  
    2. Click on the Enhanced Provider Relief Fund Payment Portal within the Medicaid/CHIP Provider Relief.

    More information on the Provider Relief Fund is also available at the following links:
    For further information about eligibility and attestation requirements, please see the Health Resources & Services Administration (HRSA) fact sheet:
    For Program Overview:,

    Thank you,
    NH Medicaid Provider Relations 

  • July 09, 2020 3:28 PM | Anonymous

    Brought to you by your NHADACA Ethics Committee

    Top Trump administration officials say drug overdose deaths are surging amid the coronavirus pandemic, driven by increased substance use due to anxiety, social isolation and depression. A White House drug policy office analysis shows an 11.4 percent year-over-year increase in fatalities for the first four months of 2020, confirming experts’ early fears that precautions like quarantines and lockdowns combined with economic uncertainty would exacerbate the addiction crisis.

    Click here to read the full article originally published 6/29/2020 and updated 7/3/2020 in Politico Magazine

  • July 06, 2020 9:10 AM | Anonymous

    Brought to you by your NHADACA Ethics Committee

    Strengthening Our Wellbeing during COVID-19

    Watch this video to access FREE wellness resources


    Pandemic Stress Hitting Parents Hard

    In this interview with Arthur C. Evans Jr., PhD, chief executive officer of the APA, he states “The mental health ramifications of the coronavirus pandemic are immense and growing . . . . we need to prepare for the long-term implications of the collective trauma facing the population. On an individual level, this means looking out for one another, staying connected, keeping active, and seeking help when necessary.”

    Click here to read the full article and learn more about current data being collected during Global Pandemic here in the US and what can be done to help coping with today’s stressors.

Sign up for a training today!

Discover professional development training events in New Hampshire & surrounding areas.

View Training Events


Stay connected with NHADACA! 

Stay Connected

Sign up to get updates, news & more!

Get in Touch

We'd love to hear from you!
130 Pembroke Road, Suite 150
Concord, NH 03301
view map
Office Hours
Monday – Friday
8AM – 4PM

Connect on Facebook

Join our facebook community! 
Powered by Wild Apricot Membership Software